Clinical Trials
ASH president discusses ‘silver lining’ of COVID-19 for hematology practice, research
At the start of his ASH presidency and a year into the COVID-19 pandemic, Martin S. Tallman, MD, reflected on the challenges the pandemic has presented to his field.
Recommendations are ‘call to action’ for African American inclusion in myeloma trials
New guidance that emerged from an FDA and American Association for Cancer Research joint workshop addresses the underrepresentation of African Americans in multiple myeloma clinical trials.
Women underrepresented in high-profile roles, late-breaker presentations at CV conferences
The proportion of women speakers at CV conferences increased from 2015 to 2019, but their inclusion in late-breaking clinical science presentations and in roles defined as high profile remains low, researchers reported.
Roswell Park promotes four physicians to leadership roles
Roswell Park Comprehensive Cancer Center has promoted four physicians to leadership roles in its clinical research program.
Q&A: Ways to mitigate underrepresentation of women in stroke clinical trials
Women are underrepresented in stroke clinical trials due to factors influenced by both investigators and patients.
Patients may be less likely to enroll on cancer trials during COVID-19 pandemic
Approximately one in five patients with cancer reported they were less likely to participate in a clinical trial because of concerns about the COVID-19 pandemic, according to a research letter in JAMA Oncology.
'This was a gift to us': Ivermectin effective for COVID-19 prophylaxis, treatment
Editor’s note: One of the studies cited in this story, conducted in Egypt, has since been retracted. The FDA has not approved ivermectin for use in treating or preventing COVID-19. Moreover, the Infectious Diseases Society of America recommends against ivermectin for the treatment of outpatients with COVID-19, unless in the context of a clinical trial.
Is the FDA’s guidance on FDAAA 810 adequate to ensure compliance?
I agree that there is a need for enforcement and compliance, which historically has not happened. However, I don’t think rigid enforcement ultimately helps patients.
Unpublished clinical trial results a ‘violation of the covenant’ with participants
The goal of most clinical trials — including those that test a medication, assess a diagnostic device or evaluate a surgical technique — is to gather and share information about the efficacy and safety of an intervention.